Last update:
Oncology & Cancer news
Oncology & Cancer
Drug combination sidesteps resistance in aggressive childhood neuroblastoma models
A discovery from Australian researchers could lead to better treatment for children with neuroblastoma, a cancer that currently claims 9 out of 10 young patients who experience recurrence. The team at the Garvan Institute ...
15 hours ago
0
0
Oncology & Cancer
Potential new second-line option for advanced biliary tract cancer identified
Biliary tract cancers, including intrahepatic, perihilar, and extrahepatic cholangiocarcinoma and gallbladder cancer, are among the most aggressive gastrointestinal malignancies. Treatment options remain limited once the ...
16 hours ago
0
0
Histotripsy: How sound waves could impact tumor treatment
For anyone facing cancer, the treatment options can feel brutally familiar: surgery, radiotherapy, chemotherapy, or a combination of them all. But a new approach is beginning to offer something very different. By using nothing ...
16 hours ago
0
0
Cognitive decline common after treatment for slow-growing brain tumors, study finds
Slow-growing brain tumors, known as IDH mutated gliomas, have a relatively good prognosis. Treatment may include surgery, radiotherapy and chemotherapy. However, a recent study, published in the journal Neuro-Oncology, shows ...
15 hours ago
0
0
Rural Australians are 13% less likely to survive cancer. Here's what needs to change
If you live in rural or remote Australia and are diagnosed with cancer, you're less likely to survive than someone in the city with the same disease. Our research shows people in rural Australia are 13% less likely to survive ...
18 hours ago
0
0
Simple blood test formula identifies patients at high risk of liver cancer
A new scoring system using common clinical parameters accurately identifies chronic liver disease patients with a significantly increased risk of developing liver cancer. This tool acts as a universal predictor, helping doctors ...
21 hours ago
0
0
Missing cancer gene explains why some lung tumors respond well to immunotherapy
For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study published in Cell Reports, Mayo Clinic researchers have found several previously unknown genetic and ...
Nov 26, 2025
0
0
High risk of metastatic recurrence found among young cancer patients
A new study of adolescents and young adults (AYAs) with seven common cancers reveals that nearly one in ten patients diagnosed with non-metastatic disease later develop metastatic recurrence—a condition associated with ...
Nov 26, 2025
0
0
Study finds uneven burden of brain and nervous system cancers across US
A new nationwide study has revealed striking differences in how brain and nervous system cancers affect Americans depending on where they live, as well as their age, sex and socioeconomic status, according to the study published ...
Nov 26, 2025
0
0
Scientists develop one-product-fits-all immunotherapy for pancreatic cancer
Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the disease has already spread throughout the body. The five-year survival rate for metastatic cases hovers around 2–3%, and median ...
Nov 25, 2025
0
35
Myeloid mimicry enables kidney tumors to resist immunotherapy and worsen rapidly, study finds
Researchers at The University of Texas MD Anderson Cancer Center have found that renal medullary carcinoma (RMC) cells use an adaptive mechanism called "myeloid mimicry" to hide from the immune system and promote disease ...
Nov 25, 2025
0
14
Cracking gastric cancer's metabolic code: Blocking cholesterol pathways slows tumor growth by 65% in mice
A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has made a breakthrough in gastric cancer research, revealing how the "second brain"—nerves in the digestive system, also known as ...
Nov 25, 2025
0
7
Shapeshifting tumors unmasked: New insights into master regulators reveal therapeutic vulnerabilities
Some tumors are almost impossible to treat. That's especially true for carcinomas, which don't behave like other malignancies. Some of these tumors act as shapeshifters and start to resemble cells from other organs of the ...
Nov 25, 2025
0
50
Calcium-sensitive switch boosts the efficacy of cancer drugs
Cancer-fighting antibody drugs are designed to penetrate tumor cells and release a lethal payload deep within, but too often they don't make it that far. A new study shows how this Trojan Horse strategy works better by exploiting ...
Nov 25, 2025
0
15
Many men may not need long-term hormone therapy for prostate cancer, study suggests
A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first 9 to 12 months. Extending ...
Nov 25, 2025
0
2
HER2-targeted therapy shows promising results in rare bile duct cancers
Zanidatamab, a bispecific HER2-targeted antibody, delivered clinically meaningful and durable responses for patients with HER2-positive biliary tract cancer (BTC), according to final results from the HERIZON-BTC-01 clinical ...
Nov 25, 2025
0
0
Tattoos could be a risk factor for melanoma
An increasing number of Swedes are getting tattoos and Sweden's population is now one of the most tattooed in Europe. At the same time, the incidence of melanoma is increasing. A new epidemiological study from Lund University ...
Nov 25, 2025
0
0
Advancing patient-reported outcomes in cancer clinical trials
The SISAQOL-IMI consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has published a paper in The Lancet Oncology outlining how its recommendations for ...
Nov 25, 2025
0
0
The cancer blood test making waves, and what the numbers really show
Progress in cutting the global toll of cancer remains painfully slow, but a new blood test has sparked unusual levels of hope. Researchers say it could one day make routine screening far more effective by catching cancers ...
Nov 25, 2025
0
1
Much-needed new drug approved for deadliest blood cancer
Biomedical research that began at the University of Virginia School of Medicine has yielded a much-needed new treatment for patients with the deadliest form of blood cancer.
Nov 25, 2025
0
1
Higher glycemic index linked to higher lung cancer risk
In a study appearing in The Annals of Family Medicine, researchers examined whether people who follow higher-GI or higher-GL diets have different risks of developing lung cancer. They used data from 101,732 adults in the ...
Nov 25, 2025
0
0
Focused ultrasound with chemotherapy shows survival benefit for brain cancer patients, clinical trial finds
Patients with the deadliest form of brain cancer, glioblastoma, who received MRI-guided focused ultrasound with standard-of-care chemotherapy had a nearly 40% increase in overall survival in a landmark trial of 34 patients ...
Nov 24, 2025
0
44
Experimental liver cancer vaccine shows promise for young patients in early trial
An experimental cancer vaccine developed at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy has shown early promise in a Phase I clinical trial for a rare form of liver cancer ...
Nov 24, 2025
0
23
Automated system enables real-time malignancy grading of prostate tumors
The precise identification of tumor boundaries during radical prostatectomy remains a major clinical challenge. As positive surgical margins occur in 15–40% of prostate cancer cases, the risk of postoperative recurrence ...
Nov 24, 2025
0
10
Researchers highlight genetic factors in pediatric brain and spinal cord tumors
Researchers at Children's Hospital of Philadelphia (CHOP) and Children's National Hospital in Washington D.C. are uncovering how rare inherited genetic variants contribute to the development of brain and spinal cord tumors ...
Nov 24, 2025
0
2
